Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

SITRYX THERAPEUTICS LIMITED

Company number 10366466

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
09 Jan 2018 SH01 Statement of capital following an allotment of shares on 21 December 2017
  • GBP 200.01
09 Jan 2018 SH02 Sub-division of shares on 21 December 2017
05 Jan 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Sub div 21/12/2017
14 Sep 2017 CS01 Confirmation statement made on 7 September 2017 with updates
14 Feb 2017 AP01 Appointment of Ms Catherine Elizabeth Bingham as a director on 1 February 2017
14 Feb 2017 AA01 Current accounting period extended from 30 September 2017 to 31 December 2017
08 Sep 2016 NEWINC Incorporation
Statement of capital on 2016-09-08
  • GBP .01
  • MODEL ARTICLES ‐ Model articles adopted